California Mandated Insurance Coverage for Scalp Cooling

New state law requires plans to cover FDA-cleared systems that reduce hair loss during chemotherapy.

Updated on Sept. 30, 2026 in Cancer

Flat opaque gouache-painted editorial illustration of a medical cooling cap and refrigeration unit resting on a minimalist surface. — Governor Gavin Newsom signed AB 1682, requiring California health plans to cover FDA-cleared scalp cooling systems to help cancer patients retain hair during chemotherapy. AI Illustration. Upload story photo >

Live Poll

Should health insurance plans be required to cover medical treatments that prevent side effects like hair loss?

California Governor Gavin Newsom signed AB 1682, which mandates that large-group health plans and Medi-Cal cover FDA-cleared scalp cooling systems for cancer patients. This change aims to improve access to technology that can help patients retain hair during treatment.

Why it matters

High out-of-pocket costs for these systems have historically created significant access disparities, with some patients even declining chemotherapy due to the financial burden. By requiring coverage, the law addresses a key barrier to a tool that preserves patient quality of life.

Clinical research suggests that FDA-cleared automated scalp cooling systems can reduce chemotherapy-induced hair loss by 50% to 75%. These systems provide a consistent cooling effect that is not achieved by manual cold caps, which remain excluded from the new state mandate.

The players

Gavin Newsom

The Governor of California who signed AB 1682 into law.

The details

Scalp cooling works by using a portable refrigeration unit attached to a fitted cap to lower the temperature of the scalp during chemotherapy. This cooling process constricts blood vessels and reduces the amount of chemotherapy drug reaching hair follicles, which helps prevent hair shedding. The mandate specifically covers automated systems such as Paxman, DigniCap, and Amma, provided the patient does not have underlying conditions involving cold sensitivity.

September 27, 2026: Governor Gavin Newsom signed AB 1682 into law.
January 1, 2027: The new insurance coverage mandate takes effect.

Health Landscape

This legislation marks a shift in how California integrates supportive cancer care into standardized benefit packages. It follows the precedent established by the California Health Benefits Review Program in identifying evidence-based, FDA-cleared technologies for mandated coverage.

Patients preparing for chemotherapy for solid tumors like breast or colon cancer should discuss the potential for scalp cooling with their oncology team. If you are a California resident, confirm your specific health plan's transition to these new coverage requirements starting in 2027.

The takeaway

Scalp cooling is a practical option for many patients to minimize hair loss during chemotherapy, though it is not suitable for everyone. Consult your physician to determine if your specific diagnosis and health history make you a candidate for this technology.